599
Participants
Start Date
February 28, 2020
Primary Completion Date
November 17, 2022
Study Completion Date
January 29, 2025
DOR/ISL
100 mg DOR/0.75 mg ISL FDC tablet taken once daily by mouth.
BIC/FTC/TAF
BIC/FTC/TAF 50/200/25 mg FDC tablet taken once daily by mouth.
Placebo to BIC/FTC/TAF
Placebo tablet matched to BIC/FTC/TAF taken by mouth.
Placebo to DOR/ISL
Placebo tablet matched to DOR/ISL taken by mouth.
National Taiwan University Hospital ( Site 7100), Taipei
Chris Hani Baragwanath Hospital - ICU ( Site 6608), Johannesburg
Wits Health Consortium. Clinical HIV Research Unit ( Site 6614), Johannesburg
Ezintsha ( Site 6609), Johannesburg
Wentworth Hospital ( Site 6607), Durban
Family Clinical Research Unit (Fam-Cru)-Adult Infectious Diseases ( Site 6617), Cape Town
Be Part Yoluntu Centre ( Site 6603), Mbekweni, Paarl
Desmond Tutu HIV Foundation Clinical Trial Unit ( Site 6613), Cape Town
JOSHA Research ( Site 6605), Bloemfontein
Ospedale Amedeo di Savoia ( Site 6414), Turin
EPIMED- Ges. f. epidemiolog. u. klin. Forschung in der Medizin mbH ( Site 6208), Berlin
University of Pennsylvania ( Site 5630), Philadelphia
Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico ( Site 6401), Milan
Salute San Raffaele ( Site 6402), Milan
Azienda Ospedaliera San Paolo ( Site 6403), Milan
ASST Fatebenefratelli-Ospedale Sacco ( Site 6400), Milan
Universitaetsklinikum Hamburg- Eppendorf (UKE) ( Site 6210), Hamburg
Ospedale San Gerardo ASST Monza ( Site 6412), Monza
Hopital Francois Mitterrand ( Site 6119), Dijon
ASST Papa Giovanni XXIII ( Site 6411), Bergamo
IRCCS Policlinico San Matteo ( Site 6410), Pavia
Hospital General Universitario Gregorio Maranon ( Site 6303), Madrid
Hospital Universitario Fundacion Jimenez Diaz ( Site 6307), Madrid
Hospital Universitario 12 de Octubre ( Site 6305), Madrid
Hospital Universitario La Paz ( Site 6304), Madrid
Hospital Universitario Virgen de la Victoria ( Site 6309), Málaga
Infectious Disease Specialists Of Atlanta PC ( Site 5608), Decatur
Columbus Regional Research Institute ( Site 5616), Columbus
Orlando Immunology Center ( Site 5613), Orlando
Floridian Clinical Research, LLC ( Site 5625), Miami Lakes
CHU de Bordeaux. Hopital Pellegrin ( Site 6116), Bordeaux
The Kinder Medical Group ( Site 5615), Miami
Triple O Research Institute, P.A. ( Site 5621), West Palm Beach
CAN Community Health ( Site 5627), Sarasota
Midway Immunology and Research ( Site 5622), Ft. Pierce
University of Alabama at Birmingham 1917 Research Clinic ( Site 5610), Birmingham
Azienda Ospedaliero Universitaria di Modena Policlinico ( Site 6404), Modena
Centre Hospitalier Regional du Orleans ( Site 6108), Orléans
Universitaetsklinikum Bonn ( Site 6200), Bonn
Hennepin Healthcare-Hennepin Healthcare-ID ( Site 5633), Minneapolis
Centre Hospitalier de Tourcoing ( Site 6100), Tourcoing
Infektiologikum ( Site 6201), Frankfurt am Main
Kansas City CARE Clinic ( Site 5607), Kansas City
Sourasky Medical Center ( Site 6705), Tel Aviv
Azienda USL di Pescara-Presidio Ospedaliero di Pescara ( Site 6413), Pescara
Hopital de la Croix-Rousse ( Site 6127), Lyon
National Cheng Kung University Hospital ( Site 7101), Tainan City
A.P.H. Paris, Hopital Saint Louis ( Site 6114), Paris
Hopital Saint-Antoine ( Site 6113), Paris
Hopital Pitie Salpetriere ( Site 6111), Paris
A.P.H. Paris. Hopital Bichat Claude Bernard ( Site 6124), Paris
North Texas ID Consultants, PA ( Site 5604), Dallas
Texas Centers for Infectious Disease Associates P.A. ( Site 5619), Fort Worth
Saint Hope Foundation, Inc. ( Site 5629), Bellaire
Universitaetsklinik Freiburg ( Site 6206), Freiburg im Breisgau
A.O.R.N. dei Colli - Ospedale Cotugno ( Site 6407), Napoli
Klinikum der LMU München ( Site 6204), Munich
MVZ Munchen am Goetheplatz ( Site 6202), Munich
Kaohsiung Veterans General Hospital ( Site 7102), Kaohsiung City
Pueblo Family Physicians ( Site 5606), Phoenix
Ruane Clinical Research Group, Inc. ( Site 5624), Los Angeles
Hopital Avicenne ( Site 6102), Bobigny
Hospital Universitario San Ignacio ( Site 6005), Bogotá
Clinica Colsanitas S.A. Sede Clinica Universitaria Colombia ( Site 6006), Bogotá
Fundacion Valle del Lili ( Site 6001), Santiago de Cali
Rambam Medical Center ( Site 6701), Haifa
Clinica Universidad Catolica del Maule ( Site 5909), Talca
Hospital Dr. Hernan Henriquez Aravena ( Site 5905), Temuco
Chaim Sheba Medical Center. ( Site 6704), Ramat Gan
Clinica Arauco Salud ( Site 5900), Santiago
Kaplan Medical Center ( Site 6700), Rehovot
Hospital Clinico de la Universidad Catolica ( Site 5903), Santiago
Fundacion Arriaran ( Site 5901), Santiago
Centro Cardiovascular Cardiosur ( Site 5907), Santiago
Hadassah Ein Kerem Medical Center ( Site 6702), Jerusalem
Helios Salud S.A. ( Site 5802), Buenos Aires
IDEAA Foundation ( Site 5807), Buenos Aires
Fundación Huesped ( Site 5801), C.a.b.a
Instituto CAICI ( Site 5803), Rosario
Instituto Oulton ( Site 5804), Córdoba
Hamilton Health Sciences- Urgent Care Centre-SIS Clinic ( Site 5703), Hamilton
Toronto General Hospital - University Health Network ( Site 5705), Toronto
Clinique Medicale L Actuel ( Site 5714), Montreal
McGill University Health Center - Research Institute-CVIS Clinical Research Unit ( Site 5702), Montreal
Istituto Nazionale per Le Malattie Infettive Lazzaro Spallanzani ( Site 6405), Roma
National Hospital Organization Nagoya Medical Center ( Site 6903), Nagoya
Kumamoto University Hospital ( Site 6905), Kumamoto
National Hospital Organization - Osaka National Hospital - Institute For Clinical Research ( Site 69, Osaka
Tokyo Medical University Hospital ( Site 6904), Tokyo
Center Hospital of the National Center for Global Health and Medicine ( Site 6901), Tokyo
Hospital General de Elche ( Site 6308), Elche
Hospital Universitari Germans Trias i Pujol ( Site 6301), Badalona
Hospital Universitari de Bellvitge ( Site 6312), LHospitalet de Llobregat
Hospital Vall D Hebron ( Site 6302), Barcelona
Hospital Clinic i Provincial ( Site 6300), Barcelona
Merck Sharp & Dohme LLC
INDUSTRY